News
Find the latest news about Inaphaea BioLabs here
-
Inaphaea BioLabs 2023: A year in review
2023 saw the launch of Inaphaea and we’re delighted to report that the company is continuing to go from strength to strength. With a strong and dedicated scientific and commercial team, and several strategic partnerships announced, our translational Contract Research Organisation (tCRO™) is now fully operational, offering cell-based assays specialising in oncology and women’s health.…
-
Inaphaea news round-up: October 2023
This roundup covers our news, updates, and highlights from October. This month was another busy one for the team, seeing us attend ELRIG Drug Discovery – a flagship event in the drug discovery sector. To discuss any of our updates, please contact Dr Andrew Carnegie, Head of Strategic Commercial Development at Inaphaea BioLabs, who will be…
-
University students complete placements with Inaphaea
In September, Inaphaea BioLabs welcomed two students from the University of Nottingham to undertake a two-week placement in the lab. The students, Daniel Abegunde and Jozaine Fenton, received a hands-on placement experience working within Inaphaea’s new lab facilities in MediCity, Nottingham. Both students were eager to learn about all aspects of working in the lab…
-
Ada Lovelace Day 2023: Zai Ahmad’s journey into STEM
In recognition of Ada Lovelace Day, Inaphaea’s Zai Ahmad shares her journey into STEM, discusses the landscape shifts she has seen within secondary education, and highlights the changes that still need to happen to encourage more women to pursue STEM as a career. Through celebrating the achievements of women in science, technology, engineering, and maths…
-
Inaphaea news roundup: September 2023
This news roundup covers our updates and highlights from September. This month, our much-anticipated lab launch event took place, and we’re pleased to say it was a resounding success. To discuss any of our updates, please contact Dr Andrew Carnegie, Head of Strategic Commercial Development at Inaphaea BioLabs, who will be happy to help. Inaphaea hosts…
-
Inaphaea BioLabs launch event
On Tuesday 26th September, Inaphaea BioLabs hosted an official launch event at its offices at MediCity Nottingham, supported by Bionow. Since opening the lab and office facilities on the old Boots site, Inaphaea has been busy establishing and building beneficial partnerships and relationships to help establish a thriving tCRO. Now, six months in, it was felt an…
-
Inaphaea news roundup: August 2023
This news roundup covers our updates and highlights from August. It has been a busy time for Inaphaea as we welcomed new faces and partnerships in preparation for the highly anticipated lab launch on 26 September. To discuss any of our updates, please contact Dr Andrew Carnegie, Head of Strategic Commercial Development at Inaphaea BioLabs, who…
-
Keynote speakers announced for Inaphaea’s lab launch event
Life science professionals are invited to gain insights from thought leaders in the industry, network, and enjoy a tour of the facilities at Inaphaea BioLabs at its official launch event supported by BioNow on 26 September. The event will run from 12pm until 5pm at Inaphaea’s labs at MediCity Nottingham and will give guests the…
-
Inaphaea BioLabs and Agility Life Sciences team up
Inaphaea BioLabs has entered into a collaborative services agreement with Agility Life Sciences to provide a single point of contact for customers to formulate and test their drug candidates. The agreement recognises the synergy between Inaphaea’s growing capabilities as a translational contract research organisation (tCRO®) and Agility’s expertise in pre-formulation and formulation development, as an…
-
Inaphaea BioLabs welcomes Dr Gareth Griffiths
We are delighted to welcome Dr Gareth Griffiths to Inaphaea BioLabs as Scientific Consultant in our Scientific Advisory Support team. Gareth holds a PhD in Immunology and Oncology from the University of Birmingham and specialises in the isolation and growth of patient-derived tumour cells. After completing his PhD, he gained several years of postdoctoral experience…